Optos plc announced that its Chairman, Dr. Peter Fellner, has resigned as a Director of Biotie Therapies Corp, and as a Director of UCB SA.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
126.2 EUR | +1.24% | +3.44% | +60.01% |
04-11 | Berenberg Reiterates UCB's Purchase Rating, Raises PT | MT |
04-11 | UCB : Berenberg, Buy, raises its price target | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.01% | 25.73B | |
-3.05% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+5.09% | 8.79B | |
-6.08% | 8.35B |
- Stock Market
- Equities
- UCB Stock
- News UCB
- Biotie Therapies Corp. and UCB SA Announce Resignation of Peter Fellner as Director